This clinical trial investigates if Spot ink can help breast surgeons retrieve the sampled lymph node as well as or better than the clip and radioseed in patients with primary breast cancer with a suspicious axillary (armpit) lymph node. It is standard of care to sample this axillary lymph node to determine if there are cancer cells inside. When the lymph node is sampled, it is standard of care to place a metallic clip, or biopsy marker, to tag or label this sampled lymph node. If the lymph node has cancer cells and is therefore positive for malignancy, the surgeon will remove this lymph node during breast cancer surgery by using the clip and a radioseed as a guide. Spot ink is a non-India black tattoo ink that can also be used to tag or label the sampled lymph node. This research study investigates if Spot ink can help breast surgeons retrieve the sampled lymph node as well as or better than the clip and radioseed.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04947917.
PRIMARY OBJECTIVE:
I. To compare technical feasibility of Spot tattoo-marked plus biopsy marker and radioseed versus biopsy marker and radioseed-localized axillary lymph nodes in patients with known breast cancer or who have imaging findings highly suspicious for breast cancer and probable axillary node involvement (Breast Imaging Reporting and Data System [BI-RADS] 4C and 5).
SECONDARY OBJECTIVE:
I. Evaluate the cost savings and efficacy of Spot ink tattooing over clip and radioseed tagging of the axillary lymph nodes.
OUTLINE:
Patients undergo lymph node sampling via fine needle aspiration or core needle biopsy per standard of care. During lymph node sampling, a standard biopsy marker/clip is placed on the axillary lymph node and Spot ink is placed on the surface of the lymph node. Patients then undergo breast surgery per standard of care.
Trial PhaseNo phase specified
Trial Typediagnostic
Lead OrganizationDana-Farber Harvard Cancer Center
Principal InvestigatorLeah Hope Portnow